<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<References xsi:schemaLocation="http://www.iedb.org/schema/CurationSchema http://beta.iedb.org/schema/Curation.xsd" xmlns="http://www.iedb.org/schema/CurationSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <Reference>
        <ReferenceId>200031</ReferenceId>
        <DateLastUpdated>2020-09-10-07:00</DateLastUpdated>
        <Article>
            <PubmedId>7541828</PubmedId>
            <Abstract>We investigated the immune response to proteolipid protein (PLP), the most abundant central nervous system myelin protein in humans. A total of 8207 short-term T cell lines were generated from 49 individuals, 39 patients with multiple sclerosis and 10 control subjects. As we have reported previously, the frequency of PLP-reactive T cells did not differ between the two groups. To determine immunodominant PLP epitopes, proliferative responses of 971 PLP-specific lines were tested with 27 overlapping 20-amino acid peptides encompassing the human PLP sequence and the binding affinities of the PLP peptides to DRB5*0101 and DRB1*1501, DR2 MHC class II isotypes associated with multiple sclerosis, were determined. The T cell response after primary PLP stimulation was focused on two immunodominant epitopes comprising residues p30-49 and p180-199. These two fragments were recognized after processing of native protein by APCs and were situated in hydrophilic regions of PLP exhibiting only moderate affinity to DR2 molecules. In contrast, when T cells from DR2+ subjects were stimulated initially by individual synthetic peptides with either high or low affinity to DRB5*0101 and DRB1*1501 isotypes, additional cryptic epitopes were recognized. MHC restriction of lines specific for the cryptic PLP epitopes were related to binding affinity to DR2 isotypes. Our results indicate that protein Ags are recognized in vivo as immunodominant epitopes after Ag processing by APCs and as cryptic epitopes after processing, presumably by extracellular proteolytic enzymes.</Abstract>
            <ArticleYear>1995</ArticleYear>
            <ArticlePages>982-92</ArticlePages>
            <ArticleTitle>T cell recognition of immunodominant and cryptic proteolipid protein epitopes in humans.</ArticleTitle>
            <Authors>
                <Author>
                    <LastName>Markovic-Plese</LastName>
                    <ForeName>S</ForeName>
                </Author>
                <Author>
                    <LastName>Fukaura</LastName>
                    <ForeName>H</ForeName>
                </Author>
                <Author>
                    <LastName>Zhang</LastName>
                    <ForeName>J</ForeName>
                </Author>
                <Author>
                    <LastName>al-Sabbagh</LastName>
                    <ForeName>A</ForeName>
                </Author>
                <Author>
                    <LastName>Southwood</LastName>
                    <ForeName>S</ForeName>
                </Author>
                <Author>
                    <LastName>Sette</LastName>
                    <ForeName>A</ForeName>
                </Author>
                <Author>
                    <LastName>Kuchroo</LastName>
                    <ForeName>V K</ForeName>
                </Author>
                <Author>
                    <LastName>Hafler</LastName>
                    <ForeName>D A</ForeName>
                </Author>
            </Authors>
            <Affiliations>Laboratory of Molecular Immunology, Brigham &amp; Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.</Affiliations>
            <ArticleChemicalList>Epitopes;HLA-DR2 Antigen;Immunodominant Epitopes;Myelin Proteins;Myelin Proteolipid Protein;Proteolipids</ArticleChemicalList>
            <ArticleMeshHeadingsList>Cell Line; Epitopes(immunology); HLA-DR2 Antigen(genetics); Humans; Immune Tolerance(immunology); Immunodominant Epitopes(immunology); Multiple Sclerosis(immunology); Myelin Proteins(immunology); Myelin Proteolipid Protein; Proteolipids(immunology); T-Lymphocytes(immunology)</ArticleMeshHeadingsList>
            <Comments>Data originally imported from the HLA Ligand Database (http://hlaligand.ouhsc.edu/)</Comments>
            <Journal>
                <Volume>155</Volume>
                <Issue>2</Issue>
                <Title>Journal of immunology (Baltimore, Md. : 1950)</Title>
                <Issn>0022-1767</Issn>
                <MedlineTa>J Immunol</MedlineTa>
            </Journal>
        </Article>
        <Epitopes>
            <Epitope>
                <EpitopeName>p230-249</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>AEFQMTFHLFIAAFVGAAAT</LinearSequence>
                        <StartingPosition>231</StartingPosition>
                        <EndingPosition>250</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P60201.2</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>9606</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 4</LocationOfData>
                <EpitopeId>909</EpitopeId>
                <ReferenceStartingPosition>230</ReferenceStartingPosition>
                <ReferenceEndingPosition>249</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Representative selection</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>Imported from the TopBank database.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 4</LocationOfData>
                        <MhcBindingId>201325</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>1</AssayTypeId>
                            <QualitativeMeasurement>Positive-High</QualitativeMeasurement>
                            <QuantitativeMeasurement>510.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>368</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 4</LocationOfData>
                        <MhcBindingId>201324</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>1</AssayTypeId>
                            <QualitativeMeasurement>Positive-Low</QualitativeMeasurement>
                            <QuantitativeMeasurement>85000.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>436</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>p20-39</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>ATGLCFFGVALFCGCGHEAL</LinearSequence>
                        <StartingPosition>21</StartingPosition>
                        <EndingPosition>40</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P60201.2</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>9606</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 5</LocationOfData>
                <EpitopeId>4970</EpitopeId>
                <ReferenceStartingPosition>20</ReferenceStartingPosition>
                <ReferenceEndingPosition>39</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Representative selection</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>Imported from the TopBank database.</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 4</LocationOfData>
                        <TCellId>1687448</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Occurrence of autoimmune disease</InVivoProcessType>
                                <DiseaseState>DOID:2377</DiseaseState>
                                <DiseaseStage>Chronic</DiseaseStage>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Primary induction in vitro</ProcessType>
                                <ResponderCellType>PBMC</ResponderCellType>
                                <StimulatorCellType>PBMC</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>ATGLCFFGVALFCGCGHEAL</LinearSequence>
                                            <StartingPosition>21</StartingPosition>
                                            <EndingPosition>40</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P60201.2</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>9606</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>Patients with definitive MS clinically characterized predominantly as early RR MS were included in the study. Patients had at least two exacerbations within the previous 24 months and positive lesions on magnetic resonance imaging at the time of blood drawing, and had not received corticosteroids for at least 10 months before the study. The average expanded disability status scale (EDSS) score was 2.5 ± 1.7. T cell lines were established by stimulation with the epitope.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>T cell</CellType>
                            <CellCultureConditions>Cell Line / Clone</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>368</MhcAlleleId>
                            <MhcEvidenceCode>MHC binding assay</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>ATGLCFFGVALFCGCGHEAL</LinearSequence>
                                        <StartingPosition>21</StartingPosition>
                                        <EndingPosition>40</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P60201.2</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>9606</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>69</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 5</LocationOfData>
                        <MhcBindingId>201327</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>1</AssayTypeId>
                            <QualitativeMeasurement>Positive-Intermediate</QualitativeMeasurement>
                            <QuantitativeMeasurement>2700.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>341</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Tables 4 and 5</LocationOfData>
                        <MhcBindingId>201332</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>1</AssayTypeId>
                            <QualitativeMeasurement>Positive-Low</QualitativeMeasurement>
                            <QuantitativeMeasurement>26000.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>368</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 5</LocationOfData>
                        <MhcBindingId>201326</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>417</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <QuantitativeMeasurement>250000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&gt;</MeasurementInequality>
                        </AssayInformation>
                        <MhcAlleleId>340</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Tables 4 and 5</LocationOfData>
                        <MhcBindingId>201328</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>417</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <QuantitativeMeasurement>250000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&gt;</MeasurementInequality>
                        </AssayInformation>
                        <MhcAlleleId>436</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 5</LocationOfData>
                        <MhcBindingId>201331</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>1</AssayTypeId>
                            <QualitativeMeasurement>Positive-Low</QualitativeMeasurement>
                            <QuantitativeMeasurement>157000.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>347</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 5</LocationOfData>
                        <MhcBindingId>201330</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>417</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <QuantitativeMeasurement>250000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&gt;</MeasurementInequality>
                        </AssayInformation>
                        <MhcAlleleId>345</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>p170-189</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>AVPVYIYFNTWTTCQSIAFP</LinearSequence>
                        <StartingPosition>171</StartingPosition>
                        <EndingPosition>190</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P60201.2</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>9606</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 5</LocationOfData>
                <EpitopeId>5516</EpitopeId>
                <ReferenceStartingPosition>170</ReferenceStartingPosition>
                <ReferenceEndingPosition>189</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Representative selection</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>Imported from the TopBank database.</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 4 and Table VI</LocationOfData>
                        <TCellId>1687449</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Occurrence of autoimmune disease</InVivoProcessType>
                                <DiseaseState>DOID:2377</DiseaseState>
                                <DiseaseStage>Chronic</DiseaseStage>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Primary induction in vitro</ProcessType>
                                <ResponderCellType>PBMC</ResponderCellType>
                                <StimulatorCellType>PBMC</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>AVPVYIYFNTWTTCQSIAFP</LinearSequence>
                                            <StartingPosition>171</StartingPosition>
                                            <EndingPosition>190</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P60201.2</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>9606</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>Patients with definitive MS clinically characterized predominantly as early RR MS were included in the study. Patients had at least two exacerbations within the previous 24 months and positive lesions on magnetic resonance imaging at the time of blood drawing, and had not received corticosteroids for at least 10 months before the study. The average expanded disability status scale (EDSS) score was 2.5 ± 1.7. T cell lines were established by stimulation with the epitope.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>T cell</CellType>
                            <CellCultureConditions>Cell Line / Clone</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>436</MhcAlleleId>
                            <MhcEvidenceCode>MHC binding assay</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>AVPVYIYFNTWTTCQSIAFP</LinearSequence>
                                        <StartingPosition>171</StartingPosition>
                                        <EndingPosition>190</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P60201.2</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>9606</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>69</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 4 and Table VI</LocationOfData>
                        <TCellId>1687450</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Occurrence of autoimmune disease</InVivoProcessType>
                                <DiseaseState>DOID:2377</DiseaseState>
                                <DiseaseStage>Chronic</DiseaseStage>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Primary induction in vitro</ProcessType>
                                <ResponderCellType>PBMC</ResponderCellType>
                                <StimulatorCellType>PBMC</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>AVPVYIYFNTWTTCQSIAFP</LinearSequence>
                                            <StartingPosition>171</StartingPosition>
                                            <EndingPosition>190</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P60201.2</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>9606</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>Patients with definitive MS clinically characterized predominantly as early RR MS were included in the study. Patients had at least two exacerbations within the previous 24 months and positive lesions on magnetic resonance imaging at the time of blood drawing, and had not received corticosteroids for at least 10 months before the study. The average expanded disability status scale (EDSS) score was 2.5 ± 1.7. T cell lines were established by stimulation with the epitope.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>T cell</CellType>
                            <CellCultureConditions>Cell Line / Clone</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>368</MhcAlleleId>
                            <MhcEvidenceCode>MHC binding assay</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>AVPVYIYFNTWTTCQSIAFP</LinearSequence>
                                        <StartingPosition>171</StartingPosition>
                                        <EndingPosition>190</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P60201.2</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>9606</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>69</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 5</LocationOfData>
                        <MhcBindingId>201334</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>1</AssayTypeId>
                            <QualitativeMeasurement>Positive-Low</QualitativeMeasurement>
                            <QuantitativeMeasurement>136000.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>340</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 5</LocationOfData>
                        <MhcBindingId>201339</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>1</AssayTypeId>
                            <QualitativeMeasurement>Positive-Low</QualitativeMeasurement>
                            <QuantitativeMeasurement>59000.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>347</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Tables 4 and 5</LocationOfData>
                        <MhcBindingId>201340</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>1</AssayTypeId>
                            <QualitativeMeasurement>Positive-High</QualitativeMeasurement>
                            <QuantitativeMeasurement>70.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>368</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 5</LocationOfData>
                        <MhcBindingId>201338</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>1</AssayTypeId>
                            <QualitativeMeasurement>Positive-Low</QualitativeMeasurement>
                            <QuantitativeMeasurement>73000.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>345</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 5</LocationOfData>
                        <MhcBindingId>201335</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>1</AssayTypeId>
                            <QualitativeMeasurement>Positive-High</QualitativeMeasurement>
                            <QuantitativeMeasurement>200.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>341</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Tables 4 and 5</LocationOfData>
                        <MhcBindingId>201336</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>1</AssayTypeId>
                            <QualitativeMeasurement>Positive-Low</QualitativeMeasurement>
                            <QuantitativeMeasurement>11000.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>436</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>p200-219</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>CADARMYGVLPWNAFPGKVC</LinearSequence>
                        <StartingPosition>201</StartingPosition>
                        <EndingPosition>220</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P60201.2</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>9606</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 4</LocationOfData>
                <EpitopeId>5967</EpitopeId>
                <ReferenceStartingPosition>200</ReferenceStartingPosition>
                <ReferenceEndingPosition>219</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Representative selection</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>Imported from the TopBank database.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 4</LocationOfData>
                        <MhcBindingId>201343</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>1</AssayTypeId>
                            <QualitativeMeasurement>Positive-High</QualitativeMeasurement>
                            <QuantitativeMeasurement>34.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>368</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 4</LocationOfData>
                        <MhcBindingId>201342</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>1</AssayTypeId>
                            <QualitativeMeasurement>Positive-Intermediate</QualitativeMeasurement>
                            <QuantitativeMeasurement>4100.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>436</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>p140-159</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>CLGKWLGHPDKFVGITYALT</LinearSequence>
                        <StartingPosition>141</StartingPosition>
                        <EndingPosition>160</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P60201.2</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>9606</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 4</LocationOfData>
                <EpitopeId>6572</EpitopeId>
                <ReferenceStartingPosition>140</ReferenceStartingPosition>
                <ReferenceEndingPosition>159</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Representative selection</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>Imported from the TopBank database.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 4</LocationOfData>
                        <MhcBindingId>201344</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>1</AssayTypeId>
                            <QualitativeMeasurement>Positive-Intermediate</QualitativeMeasurement>
                            <QuantitativeMeasurement>1800.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>436</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 4</LocationOfData>
                        <MhcBindingId>201345</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>1</AssayTypeId>
                            <QualitativeMeasurement>Positive-Intermediate</QualitativeMeasurement>
                            <QuantitativeMeasurement>4600.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>368</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>p100-119</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>FGDYKTTICGKGLSATVTGG</LinearSequence>
                        <StartingPosition>101</StartingPosition>
                        <EndingPosition>120</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P60201.2</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>9606</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 4</LocationOfData>
                <EpitopeId>15969</EpitopeId>
                <ReferenceStartingPosition>100</ReferenceStartingPosition>
                <ReferenceEndingPosition>119</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Representative selection</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>Imported from the TopBank database.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 4</LocationOfData>
                        <MhcBindingId>201347</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>1</AssayTypeId>
                            <QualitativeMeasurement>Positive-Low</QualitativeMeasurement>
                            <QuantitativeMeasurement>9100.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>368</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 4</LocationOfData>
                        <MhcBindingId>201346</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>1</AssayTypeId>
                            <QualitativeMeasurement>Positive-Intermediate</QualitativeMeasurement>
                            <QuantitativeMeasurement>2200.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>436</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>p50-69</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>FSKNYQDYEYLINVIHAFQY</LinearSequence>
                        <StartingPosition>51</StartingPosition>
                        <EndingPosition>70</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P60201.2</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>9606</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 4</LocationOfData>
                <EpitopeId>17762</EpitopeId>
                <ReferenceStartingPosition>50</ReferenceStartingPosition>
                <ReferenceEndingPosition>69</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Representative selection</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>Imported from the TopBank database.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 4</LocationOfData>
                        <MhcBindingId>201349</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>1</AssayTypeId>
                            <QualitativeMeasurement>Positive-Intermediate</QualitativeMeasurement>
                            <QuantitativeMeasurement>4600.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>368</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 4</LocationOfData>
                        <MhcBindingId>201348</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>1</AssayTypeId>
                            <QualitativeMeasurement>Positive-Intermediate</QualitativeMeasurement>
                            <QuantitativeMeasurement>3000.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>436</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>p90-109</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>FYYTTGAVRQIFGDYKTTICG</LinearSequence>
                        <SourceMolecule>
                            <IedbAccession>SRC279977</IedbAccession>
                        </SourceMolecule>
                        <SourceOrganismId>9606</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 5</LocationOfData>
                <EpitopeId>18488</EpitopeId>
                <ReferenceStartingPosition>90</ReferenceStartingPosition>
                <ReferenceEndingPosition>109</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Internal Identifier-no external match available</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>Imported from the TopBank database.</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 4</LocationOfData>
                        <TCellId>1687451</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Occurrence of autoimmune disease</InVivoProcessType>
                                <DiseaseState>DOID:2377</DiseaseState>
                                <DiseaseStage>Chronic</DiseaseStage>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Primary induction in vitro</ProcessType>
                                <ResponderCellType>PBMC</ResponderCellType>
                                <StimulatorCellType>PBMC</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>FYYTTGAVRQIFGDYKTTICG</LinearSequence>
                                            <SourceMolecule>
                                                <IedbAccession>SRC279977</IedbAccession>
                                            </SourceMolecule>
                                            <SourceOrganismId>9606</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>Patients with definitive MS clinically characterized predominantly as early RR MS were included in the study. Patients had at least two exacerbations within the previous 24 months and positive lesions on magnetic resonance imaging at the time of blood drawing, and had not received corticosteroids for at least 10 months before the study. The average expanded disability status scale (EDSS) score was 2.5 ± 1.7. T cell lines were established by stimulation with the epitope.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>T cell</CellType>
                            <CellCultureConditions>Cell Line / Clone</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>436</MhcAlleleId>
                            <MhcEvidenceCode>MHC binding assay</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>FYYTTGAVRQIFGDYKTTICG</LinearSequence>
                                        <SourceMolecule>
                                            <IedbAccession>SRC279977</IedbAccession>
                                        </SourceMolecule>
                                        <SourceOrganismId>9606</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>69</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 4</LocationOfData>
                        <TCellId>1687452</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Occurrence of autoimmune disease</InVivoProcessType>
                                <DiseaseState>DOID:2377</DiseaseState>
                                <DiseaseStage>Chronic</DiseaseStage>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Primary induction in vitro</ProcessType>
                                <ResponderCellType>PBMC</ResponderCellType>
                                <StimulatorCellType>PBMC</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>FYYTTGAVRQIFGDYKTTICG</LinearSequence>
                                            <SourceMolecule>
                                                <IedbAccession>SRC279977</IedbAccession>
                                            </SourceMolecule>
                                            <SourceOrganismId>9606</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>Patients with definitive MS clinically characterized predominantly as early RR MS were included in the study. Patients had at least two exacerbations within the previous 24 months and positive lesions on magnetic resonance imaging at the time of blood drawing, and had not received corticosteroids for at least 10 months before the study. The average expanded disability status scale (EDSS) score was 2.5 ± 1.7. T cell lines were established by stimulation with the epitope.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>T cell</CellType>
                            <CellCultureConditions>Cell Line / Clone</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>368</MhcAlleleId>
                            <MhcEvidenceCode>MHC binding assay</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>FYYTTGAVRQIFGDYKTTICG</LinearSequence>
                                        <SourceMolecule>
                                            <IedbAccession>SRC279977</IedbAccession>
                                        </SourceMolecule>
                                        <SourceOrganismId>9606</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>69</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 5</LocationOfData>
                        <MhcBindingId>201350</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>1</AssayTypeId>
                            <QualitativeMeasurement>Positive-High</QualitativeMeasurement>
                            <QuantitativeMeasurement>140.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>340</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Tables 4 and 5</LocationOfData>
                        <MhcBindingId>201352</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>1</AssayTypeId>
                            <QualitativeMeasurement>Positive-High</QualitativeMeasurement>
                            <QuantitativeMeasurement>22.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>436</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 5</LocationOfData>
                        <MhcBindingId>201354</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>1</AssayTypeId>
                            <QualitativeMeasurement>Positive-Low</QualitativeMeasurement>
                            <QuantitativeMeasurement>7800.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>345</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 5</LocationOfData>
                        <MhcBindingId>201355</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>1</AssayTypeId>
                            <QualitativeMeasurement>Positive-High</QualitativeMeasurement>
                            <QuantitativeMeasurement>41.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>347</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Tables 4 and 5</LocationOfData>
                        <MhcBindingId>201356</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>1</AssayTypeId>
                            <QualitativeMeasurement>Positive-High</QualitativeMeasurement>
                            <QuantitativeMeasurement>65.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>368</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 5</LocationOfData>
                        <MhcBindingId>201351</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>1</AssayTypeId>
                            <QualitativeMeasurement>Positive-High</QualitativeMeasurement>
                            <QuantitativeMeasurement>340.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>341</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>p220-239</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>GSNLLSICKTAEFQMTFHLF</LinearSequence>
                        <StartingPosition>221</StartingPosition>
                        <EndingPosition>240</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P60201.2</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>9606</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 4</LocationOfData>
                <EpitopeId>22429</EpitopeId>
                <ReferenceStartingPosition>220</ReferenceStartingPosition>
                <ReferenceEndingPosition>239</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Representative selection</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>Imported from the TopBank database.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 4</LocationOfData>
                        <MhcBindingId>201358</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>1</AssayTypeId>
                            <QualitativeMeasurement>Positive-Intermediate</QualitativeMeasurement>
                            <QuantitativeMeasurement>1100.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>436</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 4</LocationOfData>
                        <MhcBindingId>201359</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>1</AssayTypeId>
                            <QualitativeMeasurement>Positive-Intermediate</QualitativeMeasurement>
                            <QuantitativeMeasurement>2300.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>368</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>p240-259</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>IAAFVGAAATLVSLLTFMIA</LinearSequence>
                        <StartingPosition>241</StartingPosition>
                        <EndingPosition>260</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P60201.2</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>9606</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 4</LocationOfData>
                <EpitopeId>25220</EpitopeId>
                <ReferenceStartingPosition>240</ReferenceStartingPosition>
                <ReferenceEndingPosition>259</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Representative selection</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>Imported from the TopBank database.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 4</LocationOfData>
                        <MhcBindingId>201360</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>1</AssayTypeId>
                            <QualitativeMeasurement>Positive-Intermediate</QualitativeMeasurement>
                            <QuantitativeMeasurement>4700.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>436</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 4</LocationOfData>
                        <MhcBindingId>201361</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>1</AssayTypeId>
                            <QualitativeMeasurement>Positive-High</QualitativeMeasurement>
                            <QuantitativeMeasurement>700.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>368</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>p150-169</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>KFVGITYALTVVWLLVFACS</LinearSequence>
                        <StartingPosition>151</StartingPosition>
                        <EndingPosition>170</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P60201.2</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>9606</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 4</LocationOfData>
                <EpitopeId>30875</EpitopeId>
                <ReferenceStartingPosition>150</ReferenceStartingPosition>
                <ReferenceEndingPosition>169</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Representative selection</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>Imported from the TopBank database.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 4</LocationOfData>
                        <MhcBindingId>201363</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>1</AssayTypeId>
                            <QualitativeMeasurement>Positive-Low</QualitativeMeasurement>
                            <QuantitativeMeasurement>165000.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>368</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 4</LocationOfData>
                        <MhcBindingId>201362</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>1</AssayTypeId>
                            <QualitativeMeasurement>Positive-Low</QualitativeMeasurement>
                            <QuantitativeMeasurement>13000.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>436</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>p110-129</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>KGLSATVTGGQKGRGYRGQH</LinearSequence>
                        <SourceMolecule>
                            <IedbAccession>SRC279977</IedbAccession>
                        </SourceMolecule>
                        <SourceOrganismId>9606</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 5</LocationOfData>
                <EpitopeId>31008</EpitopeId>
                <ReferenceStartingPosition>110</ReferenceStartingPosition>
                <ReferenceEndingPosition>129</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Internal Identifier-no external match available</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>Imported from the TopBank database.</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 4</LocationOfData>
                        <TCellId>1687446</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Occurrence of autoimmune disease</InVivoProcessType>
                                <DiseaseState>DOID:2377</DiseaseState>
                                <DiseaseStage>Chronic</DiseaseStage>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Primary induction in vitro</ProcessType>
                                <ResponderCellType>PBMC</ResponderCellType>
                                <StimulatorCellType>PBMC</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>KGLSATVTGGQKGRGYRGQH</LinearSequence>
                                            <SourceMolecule>
                                                <IedbAccession>SRC279977</IedbAccession>
                                            </SourceMolecule>
                                            <SourceOrganismId>9606</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>Patients with definitive MS clinically characterized predominantly as early RR MS were included in the study. Patients had at least two exacerbations within the previous 24 months and positive lesions on magnetic resonance imaging at the time of blood drawing, and had not received corticosteroids for at least 10 months before the study. The average expanded disability status scale (EDSS) score was 2.5 ± 1.7. T cell lines were established by stimulation with the epitope.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>T cell</CellType>
                            <CellCultureConditions>Cell Line / Clone</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>436</MhcAlleleId>
                            <MhcEvidenceCode>MHC binding assay</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>KGLSATVTGGQKGRGYRGQH</LinearSequence>
                                        <SourceMolecule>
                                            <IedbAccession>SRC279977</IedbAccession>
                                        </SourceMolecule>
                                        <SourceOrganismId>9606</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>69</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 5</LocationOfData>
                        <MhcBindingId>201365</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>1</AssayTypeId>
                            <QualitativeMeasurement>Positive-Low</QualitativeMeasurement>
                            <QuantitativeMeasurement>9100.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>341</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Tables 4 and 5</LocationOfData>
                        <MhcBindingId>201366</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>1</AssayTypeId>
                            <QualitativeMeasurement>Positive-Intermediate</QualitativeMeasurement>
                            <QuantitativeMeasurement>2900.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>436</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 5</LocationOfData>
                        <MhcBindingId>201368</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>417</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <QuantitativeMeasurement>250000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&gt;</MeasurementInequality>
                        </AssayInformation>
                        <MhcAlleleId>345</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 5</LocationOfData>
                        <MhcBindingId>201369</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>1</AssayTypeId>
                            <QualitativeMeasurement>Positive-Low</QualitativeMeasurement>
                            <QuantitativeMeasurement>39000.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>347</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 5</LocationOfData>
                        <MhcBindingId>201364</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>417</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <QuantitativeMeasurement>250000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&gt;</MeasurementInequality>
                        </AssayInformation>
                        <MhcAlleleId>340</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Tables 4 and 5</LocationOfData>
                        <MhcBindingId>201370</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>417</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <QuantitativeMeasurement>250000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&gt;</MeasurementInequality>
                        </AssayInformation>
                        <MhcAlleleId>368</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>p30-49</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>LFCGCGHEALTGTEKLIETY</LinearSequence>
                        <StartingPosition>31</StartingPosition>
                        <EndingPosition>50</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P60201.2</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>9606</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 5</LocationOfData>
                <EpitopeId>35803</EpitopeId>
                <ReferenceStartingPosition>30</ReferenceStartingPosition>
                <ReferenceEndingPosition>49</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Representative selection</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>Imported from the TopBank database.</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 4</LocationOfData>
                        <TCellId>1687453</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Occurrence of autoimmune disease</InVivoProcessType>
                                <DiseaseState>DOID:2377</DiseaseState>
                                <DiseaseStage>Chronic</DiseaseStage>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Primary induction in vitro</ProcessType>
                                <ResponderCellType>PBMC</ResponderCellType>
                                <StimulatorCellType>PBMC</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>LFCGCGHEALTGTEKLIETY</LinearSequence>
                                            <StartingPosition>31</StartingPosition>
                                            <EndingPosition>50</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P60201.2</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>9606</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>Patients with definitive MS clinically characterized predominantly as early RR MS were included in the study. Patients had at least two exacerbations within the previous 24 months and positive lesions on magnetic resonance imaging at the time of blood drawing, and had not received corticosteroids for at least 10 months before the study. The average expanded disability status scale (EDSS) score was 2.5 ± 1.7. T cell lines were established by stimulation with the epitope.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>T cell</CellType>
                            <CellCultureConditions>Cell Line / Clone</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>436</MhcAlleleId>
                            <MhcEvidenceCode>MHC binding assay</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>LFCGCGHEALTGTEKLIETY</LinearSequence>
                                        <StartingPosition>31</StartingPosition>
                                        <EndingPosition>50</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P60201.2</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>9606</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>69</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figures 1, 2, 3, and 4, Tables II and III</LocationOfData>
                        <TCellId>1687438</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Occurrence of autoimmune disease</InVivoProcessType>
                                <DiseaseState>DOID:2377</DiseaseState>
                                <DiseaseStage>Chronic</DiseaseStage>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Primary induction in vitro</ProcessType>
                                <ResponderCellType>PBMC</ResponderCellType>
                                <StimulatorCellType>PBMC</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P60201.2</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>9606</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Representative selection</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>Patients with definitive MS clinically characterized predominantly as early RR MS were included in the study. Patients had at least two exacerbations within the previous 24 months and positive lesions on magnetic resonance imaging at the time of blood drawing, and had not received corticosteroids for at least 10 months before the study. The average expanded disability status scale (EDSS) score was 2.5 ± 1.7. T cell lines were established by stimulation with PLP.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>T cell</CellType>
                            <CellCultureConditions>Cell Line / Clone</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>436</MhcAlleleId>
                            <MhcEvidenceCode>MHC binding assay</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>LFCGCGHEALTGTEKLIETY</LinearSequence>
                                        <StartingPosition>31</StartingPosition>
                                        <EndingPosition>50</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P60201.2</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>9606</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>69</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figures 1, 2, 3, and 4, Tables II and III</LocationOfData>
                        <TCellId>1687439</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Occurrence of autoimmune disease</InVivoProcessType>
                                <DiseaseState>DOID:2377</DiseaseState>
                                <DiseaseStage>Chronic</DiseaseStage>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Primary induction in vitro</ProcessType>
                                <ResponderCellType>PBMC</ResponderCellType>
                                <StimulatorCellType>PBMC</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P60201.2</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>9606</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Representative selection</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>Patients with definitive MS clinically characterized predominantly as early RR MS were included in the study. Patients had at least two exacerbations within the previous 24 months and positive lesions on magnetic resonance imaging at the time of blood drawing, and had not received corticosteroids for at least 10 months before the study. The average expanded disability status scale (EDSS) score was 2.5 ± 1.7. T cell lines were established by stimulation with PLP.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>T cell</CellType>
                            <CellCultureConditions>Cell Line / Clone</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>368</MhcAlleleId>
                            <MhcEvidenceCode>MHC binding assay</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>LFCGCGHEALTGTEKLIETY</LinearSequence>
                                        <StartingPosition>31</StartingPosition>
                                        <EndingPosition>50</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P60201.2</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>9606</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>69</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 4</LocationOfData>
                        <TCellId>1687454</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Occurrence of autoimmune disease</InVivoProcessType>
                                <DiseaseState>DOID:2377</DiseaseState>
                                <DiseaseStage>Chronic</DiseaseStage>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Primary induction in vitro</ProcessType>
                                <ResponderCellType>PBMC</ResponderCellType>
                                <StimulatorCellType>PBMC</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>LFCGCGHEALTGTEKLIETY</LinearSequence>
                                            <StartingPosition>31</StartingPosition>
                                            <EndingPosition>50</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P60201.2</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>9606</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>Patients with definitive MS clinically characterized predominantly as early RR MS were included in the study. Patients had at least two exacerbations within the previous 24 months and positive lesions on magnetic resonance imaging at the time of blood drawing, and had not received corticosteroids for at least 10 months before the study. The average expanded disability status scale (EDSS) score was 2.5 ± 1.7. T cell lines were established by stimulation with the epitope.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>T cell</CellType>
                            <CellCultureConditions>Cell Line / Clone</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>368</MhcAlleleId>
                            <MhcEvidenceCode>MHC binding assay</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>LFCGCGHEALTGTEKLIETY</LinearSequence>
                                        <StartingPosition>31</StartingPosition>
                                        <EndingPosition>50</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P60201.2</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>9606</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>69</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 5</LocationOfData>
                        <MhcBindingId>201373</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>417</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <QuantitativeMeasurement>225000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&gt;</MeasurementInequality>
                        </AssayInformation>
                        <MhcAlleleId>341</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Tables 4 and 5</LocationOfData>
                        <MhcBindingId>201374</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>1</AssayTypeId>
                            <QualitativeMeasurement>Positive-Low</QualitativeMeasurement>
                            <QuantitativeMeasurement>49000.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>436</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 5</LocationOfData>
                        <MhcBindingId>201376</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>417</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <QuantitativeMeasurement>250000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&gt;</MeasurementInequality>
                        </AssayInformation>
                        <MhcAlleleId>345</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 5</LocationOfData>
                        <MhcBindingId>201377</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>417</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <QuantitativeMeasurement>235000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&gt;</MeasurementInequality>
                        </AssayInformation>
                        <MhcAlleleId>347</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 5</LocationOfData>
                        <MhcBindingId>201372</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>417</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <QuantitativeMeasurement>250000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&gt;</MeasurementInequality>
                        </AssayInformation>
                        <MhcAlleleId>340</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Tables 4 and 5</LocationOfData>
                        <MhcBindingId>201378</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>1</AssayTypeId>
                            <QualitativeMeasurement>Positive-Intermediate</QualitativeMeasurement>
                            <QuantitativeMeasurement>1500.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>368</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>p60-79</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>LINVIHAFQYVIYGTASFFF</LinearSequence>
                        <StartingPosition>61</StartingPosition>
                        <EndingPosition>80</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P60201.2</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>9606</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 4</LocationOfData>
                <EpitopeId>36651</EpitopeId>
                <ReferenceStartingPosition>60</ReferenceStartingPosition>
                <ReferenceEndingPosition>79</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Representative selection</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>Imported from the TopBank database.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 4</LocationOfData>
                        <MhcBindingId>201380</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>1</AssayTypeId>
                            <QualitativeMeasurement>Positive-Low</QualitativeMeasurement>
                            <QuantitativeMeasurement>70000.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>436</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 4</LocationOfData>
                        <MhcBindingId>201381</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>1</AssayTypeId>
                            <QualitativeMeasurement>Positive-Intermediate</QualitativeMeasurement>
                            <QuantitativeMeasurement>1500.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>368</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>p10-29</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>LVGAPFASLVATGLCFFGVA</LinearSequence>
                        <StartingPosition>11</StartingPosition>
                        <EndingPosition>30</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P60201.2</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>9606</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 5</LocationOfData>
                <EpitopeId>40353</EpitopeId>
                <ReferenceStartingPosition>10</ReferenceStartingPosition>
                <ReferenceEndingPosition>29</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Representative selection</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>Imported from the TopBank database.</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 4 and Table VI</LocationOfData>
                        <TCellId>1687444</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Occurrence of autoimmune disease</InVivoProcessType>
                                <DiseaseState>DOID:2377</DiseaseState>
                                <DiseaseStage>Chronic</DiseaseStage>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Primary induction in vitro</ProcessType>
                                <ResponderCellType>PBMC</ResponderCellType>
                                <StimulatorCellType>PBMC</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>LVGAPFASLVATGLCFFGVA</LinearSequence>
                                            <StartingPosition>11</StartingPosition>
                                            <EndingPosition>30</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P60201.2</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>9606</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>Patients with definitive MS clinically characterized predominantly as early RR MS were included in the study. Patients had at least two exacerbations within the previous 24 months and positive lesions on magnetic resonance imaging at the time of blood drawing, and had not received corticosteroids for at least 10 months before the study. The average expanded disability status scale (EDSS) score was 2.5 ± 1.7. T cell lines were established by stimulation with the epitope.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>T cell</CellType>
                            <CellCultureConditions>Cell Line / Clone</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>436</MhcAlleleId>
                            <MhcEvidenceCode>MHC binding assay</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>LVGAPFASLVATGLCFFGVA</LinearSequence>
                                        <StartingPosition>11</StartingPosition>
                                        <EndingPosition>30</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P60201.2</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>9606</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>69</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Tables 4 and 5</LocationOfData>
                        <MhcBindingId>201384</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>1</AssayTypeId>
                            <QualitativeMeasurement>Positive-Low</QualitativeMeasurement>
                            <QuantitativeMeasurement>6000.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>436</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 5</LocationOfData>
                        <MhcBindingId>201387</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>1</AssayTypeId>
                            <QualitativeMeasurement>Positive-Low</QualitativeMeasurement>
                            <QuantitativeMeasurement>94000.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>347</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Tables 4 and 5</LocationOfData>
                        <MhcBindingId>201388</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>417</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <QuantitativeMeasurement>250000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&gt;</MeasurementInequality>
                        </AssayInformation>
                        <MhcAlleleId>368</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 5</LocationOfData>
                        <MhcBindingId>201382</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>417</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <QuantitativeMeasurement>250000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&gt;</MeasurementInequality>
                        </AssayInformation>
                        <MhcAlleleId>340</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 5</LocationOfData>
                        <MhcBindingId>201383</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>1</AssayTypeId>
                            <QualitativeMeasurement>Positive-Low</QualitativeMeasurement>
                            <QuantitativeMeasurement>17000.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>341</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 5</LocationOfData>
                        <MhcBindingId>201386</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>417</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <QuantitativeMeasurement>250000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&gt;</MeasurementInequality>
                        </AssayInformation>
                        <MhcAlleleId>345</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>p250-269</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>LVSLLTFMIAATYNFAVLKL</LinearSequence>
                        <StartingPosition>251</StartingPosition>
                        <EndingPosition>270</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P60201.2</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>9606</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 4</LocationOfData>
                <EpitopeId>40592</EpitopeId>
                <ReferenceStartingPosition>250</ReferenceStartingPosition>
                <ReferenceEndingPosition>269</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Representative selection</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>Imported from the TopBank database.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 4</LocationOfData>
                        <MhcBindingId>201390</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>1</AssayTypeId>
                            <QualitativeMeasurement>Positive-Intermediate</QualitativeMeasurement>
                            <QuantitativeMeasurement>4400.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>436</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 4</LocationOfData>
                        <MhcBindingId>201391</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>1</AssayTypeId>
                            <QualitativeMeasurement>Positive-High</QualitativeMeasurement>
                            <QuantitativeMeasurement>1000.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>368</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>p80-99</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>LYGALLLAEGFYTTGAVRQI</LinearSequence>
                        <StartingPosition>81</StartingPosition>
                        <EndingPosition>100</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P60201.2</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>9606</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 5</LocationOfData>
                <EpitopeId>40762</EpitopeId>
                <ReferenceStartingPosition>80</ReferenceStartingPosition>
                <ReferenceEndingPosition>99</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Representative selection</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>Imported from the TopBank database.</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 4</LocationOfData>
                        <TCellId>1687455</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Occurrence of autoimmune disease</InVivoProcessType>
                                <DiseaseState>DOID:2377</DiseaseState>
                                <DiseaseStage>Chronic</DiseaseStage>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Primary induction in vitro</ProcessType>
                                <ResponderCellType>PBMC</ResponderCellType>
                                <StimulatorCellType>PBMC</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>LYGALLLAEGFYTTGAVRQI</LinearSequence>
                                            <StartingPosition>81</StartingPosition>
                                            <EndingPosition>100</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P60201.2</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>9606</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>Patients with definitive MS clinically characterized predominantly as early RR MS were included in the study. Patients had at least two exacerbations within the previous 24 months and positive lesions on magnetic resonance imaging at the time of blood drawing, and had not received corticosteroids for at least 10 months before the study. The average expanded disability status scale (EDSS) score was 2.5 ± 1.7. T cell lines were established by stimulation with the epitope.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>T cell</CellType>
                            <CellCultureConditions>Cell Line / Clone</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>436</MhcAlleleId>
                            <MhcEvidenceCode>MHC binding assay</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>LYGALLLAEGFYTTGAVRQI</LinearSequence>
                                        <StartingPosition>81</StartingPosition>
                                        <EndingPosition>100</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P60201.2</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>9606</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>69</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 4</LocationOfData>
                        <TCellId>1687456</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Occurrence of autoimmune disease</InVivoProcessType>
                                <DiseaseState>DOID:2377</DiseaseState>
                                <DiseaseStage>Chronic</DiseaseStage>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Primary induction in vitro</ProcessType>
                                <ResponderCellType>PBMC</ResponderCellType>
                                <StimulatorCellType>PBMC</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>LYGALLLAEGFYTTGAVRQI</LinearSequence>
                                            <StartingPosition>81</StartingPosition>
                                            <EndingPosition>100</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P60201.2</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>9606</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>Patients with definitive MS clinically characterized predominantly as early RR MS were included in the study. Patients had at least two exacerbations within the previous 24 months and positive lesions on magnetic resonance imaging at the time of blood drawing, and had not received corticosteroids for at least 10 months before the study. The average expanded disability status scale (EDSS) score was 2.5 ± 1.7. T cell lines were established by stimulation with the epitope.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>T cell</CellType>
                            <CellCultureConditions>Cell Line / Clone</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>368</MhcAlleleId>
                            <MhcEvidenceCode>MHC binding assay</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>LYGALLLAEGFYTTGAVRQI</LinearSequence>
                                        <StartingPosition>81</StartingPosition>
                                        <EndingPosition>100</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P60201.2</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>9606</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>69</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 5</LocationOfData>
                        <MhcBindingId>201393</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>1</AssayTypeId>
                            <QualitativeMeasurement>Positive-High</QualitativeMeasurement>
                            <QuantitativeMeasurement>500.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>341</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 5</LocationOfData>
                        <MhcBindingId>201396</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>417</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <QuantitativeMeasurement>250000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&gt;</MeasurementInequality>
                        </AssayInformation>
                        <MhcAlleleId>345</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Tables 4 and 5</LocationOfData>
                        <MhcBindingId>201398</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>1</AssayTypeId>
                            <QualitativeMeasurement>Positive-High</QualitativeMeasurement>
                            <QuantitativeMeasurement>18.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>368</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 5</LocationOfData>
                        <MhcBindingId>201392</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>417</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <QuantitativeMeasurement>250000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&gt;</MeasurementInequality>
                        </AssayInformation>
                        <MhcAlleleId>340</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Tables 4 and 5</LocationOfData>
                        <MhcBindingId>201394</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>1</AssayTypeId>
                            <QualitativeMeasurement>Positive-High</QualitativeMeasurement>
                            <QuantitativeMeasurement>140.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>436</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 5</LocationOfData>
                        <MhcBindingId>201397</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>1</AssayTypeId>
                            <QualitativeMeasurement>Positive-High</QualitativeMeasurement>
                            <QuantitativeMeasurement>810.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>347</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>p260-276</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>MAATYNFAVLKLMGRFTKF</LinearSequence>
                        <SourceMolecule>
                            <IedbAccession>SRC279977</IedbAccession>
                        </SourceMolecule>
                        <SourceOrganismId>9606</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 5</LocationOfData>
                <EpitopeId>41007</EpitopeId>
                <ReferenceStartingPosition>260</ReferenceStartingPosition>
                <ReferenceEndingPosition>276</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Internal Identifier-no external match available</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>Imported from the TopBank database.</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 4</LocationOfData>
                        <TCellId>1687457</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Occurrence of autoimmune disease</InVivoProcessType>
                                <DiseaseState>DOID:2377</DiseaseState>
                                <DiseaseStage>Chronic</DiseaseStage>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Primary induction in vitro</ProcessType>
                                <ResponderCellType>PBMC</ResponderCellType>
                                <StimulatorCellType>PBMC</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>MAATYNFAVLKLMGRFTKF</LinearSequence>
                                            <SourceMolecule>
                                                <IedbAccession>SRC279977</IedbAccession>
                                            </SourceMolecule>
                                            <SourceOrganismId>9606</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>Patients with definitive MS clinically characterized predominantly as early RR MS were included in the study. Patients had at least two exacerbations within the previous 24 months and positive lesions on magnetic resonance imaging at the time of blood drawing, and had not received corticosteroids for at least 10 months before the study. The average expanded disability status scale (EDSS) score was 2.5 ± 1.7. T cell lines were established by stimulation with the epitope.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>T cell</CellType>
                            <CellCultureConditions>Cell Line / Clone</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>436</MhcAlleleId>
                            <MhcEvidenceCode>MHC binding assay</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>MAATYNFAVLKLMGRFTKF</LinearSequence>
                                        <SourceMolecule>
                                            <IedbAccession>SRC279977</IedbAccession>
                                        </SourceMolecule>
                                        <SourceOrganismId>9606</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>69</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 4</LocationOfData>
                        <TCellId>1687458</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Occurrence of autoimmune disease</InVivoProcessType>
                                <DiseaseState>DOID:2377</DiseaseState>
                                <DiseaseStage>Chronic</DiseaseStage>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Primary induction in vitro</ProcessType>
                                <ResponderCellType>PBMC</ResponderCellType>
                                <StimulatorCellType>PBMC</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>MAATYNFAVLKLMGRFTKF</LinearSequence>
                                            <SourceMolecule>
                                                <IedbAccession>SRC279977</IedbAccession>
                                            </SourceMolecule>
                                            <SourceOrganismId>9606</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>Patients with definitive MS clinically characterized predominantly as early RR MS were included in the study. Patients had at least two exacerbations within the previous 24 months and positive lesions on magnetic resonance imaging at the time of blood drawing, and had not received corticosteroids for at least 10 months before the study. The average expanded disability status scale (EDSS) score was 2.5 ± 1.7. T cell lines were established by stimulation with the epitope.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>T cell</CellType>
                            <CellCultureConditions>Cell Line / Clone</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>368</MhcAlleleId>
                            <MhcEvidenceCode>MHC binding assay</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>MAATYNFAVLKLMGRFTKF</LinearSequence>
                                        <SourceMolecule>
                                            <IedbAccession>SRC279977</IedbAccession>
                                        </SourceMolecule>
                                        <SourceOrganismId>9606</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>69</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 5</LocationOfData>
                        <MhcBindingId>201401</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>1</AssayTypeId>
                            <QualitativeMeasurement>Positive-Intermediate</QualitativeMeasurement>
                            <QuantitativeMeasurement>3000.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>341</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Tables 4 and 5</LocationOfData>
                        <MhcBindingId>201402</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>1</AssayTypeId>
                            <QualitativeMeasurement>Positive-High</QualitativeMeasurement>
                            <QuantitativeMeasurement>12.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>436</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 5</LocationOfData>
                        <MhcBindingId>201404</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>417</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <QuantitativeMeasurement>250000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&gt;</MeasurementInequality>
                        </AssayInformation>
                        <MhcAlleleId>345</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 5</LocationOfData>
                        <MhcBindingId>201405</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>1</AssayTypeId>
                            <QualitativeMeasurement>Positive-High</QualitativeMeasurement>
                            <QuantitativeMeasurement>850.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>347</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 5</LocationOfData>
                        <MhcBindingId>201400</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>417</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <QuantitativeMeasurement>250000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&gt;</MeasurementInequality>
                        </AssayInformation>
                        <MhcAlleleId>340</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Tables 4 and 5</LocationOfData>
                        <MhcBindingId>201406</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>1</AssayTypeId>
                            <QualitativeMeasurement>Positive-High</QualitativeMeasurement>
                            <QuantitativeMeasurement>190.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>368</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>p1-19</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>MGLLECCARCLVGAPFASLV</LinearSequence>
                        <StartingPosition>1</StartingPosition>
                        <EndingPosition>20</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>AAA60350.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>9606</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 4</LocationOfData>
                <EpitopeId>41605</EpitopeId>
                <ReferenceStartingPosition>1</ReferenceStartingPosition>
                <ReferenceEndingPosition>19</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Representative selection</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>Imported from the TopBank database.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 4</LocationOfData>
                        <MhcBindingId>201409</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>1</AssayTypeId>
                            <QualitativeMeasurement>Positive-Intermediate</QualitativeMeasurement>
                            <QuantitativeMeasurement>1800.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>368</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 4</LocationOfData>
                        <MhcBindingId>201408</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>417</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <QuantitativeMeasurement>250000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&gt;</MeasurementInequality>
                        </AssayInformation>
                        <MhcAlleleId>436</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>p210-229</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>PWNAFPGKVCGSNLLSICKT</LinearSequence>
                        <StartingPosition>211</StartingPosition>
                        <EndingPosition>230</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P60201.2</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>9606</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 4</LocationOfData>
                <EpitopeId>50042</EpitopeId>
                <ReferenceStartingPosition>210</ReferenceStartingPosition>
                <ReferenceEndingPosition>229</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Representative selection</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>Imported from the TopBank database.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 4</LocationOfData>
                        <MhcBindingId>201410</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>1</AssayTypeId>
                            <QualitativeMeasurement>Positive-Intermediate</QualitativeMeasurement>
                            <QuantitativeMeasurement>1400.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>436</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 4</LocationOfData>
                        <MhcBindingId>201411</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>1</AssayTypeId>
                            <QualitativeMeasurement>Positive-Intermediate</QualitativeMeasurement>
                            <QuantitativeMeasurement>1300.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>368</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>p130-149</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>QAHSLERVCHCLGKWLGHPD</LinearSequence>
                        <StartingPosition>131</StartingPosition>
                        <EndingPosition>150</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P60201.2</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>9606</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 4</LocationOfData>
                <EpitopeId>50275</EpitopeId>
                <ReferenceStartingPosition>130</ReferenceStartingPosition>
                <ReferenceEndingPosition>149</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Representative selection</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>Imported from the TopBank database.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 4</LocationOfData>
                        <MhcBindingId>201412</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>1</AssayTypeId>
                            <QualitativeMeasurement>Positive-Intermediate</QualitativeMeasurement>
                            <QuantitativeMeasurement>2100.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>436</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 4</LocationOfData>
                        <MhcBindingId>201413</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>1</AssayTypeId>
                            <QualitativeMeasurement>Positive-Intermediate</QualitativeMeasurement>
                            <QuantitativeMeasurement>4600.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>368</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>p120-139</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>QKGRGSRGQHQAHSLERVCH</LinearSequence>
                        <StartingPosition>121</StartingPosition>
                        <EndingPosition>140</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P60201.2</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>9606</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 5</LocationOfData>
                <EpitopeId>51191</EpitopeId>
                <ReferenceStartingPosition>120</ReferenceStartingPosition>
                <ReferenceEndingPosition>139</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Representative selection</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>Imported from the TopBank database.</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 4</LocationOfData>
                        <TCellId>1687447</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Occurrence of autoimmune disease</InVivoProcessType>
                                <DiseaseState>DOID:2377</DiseaseState>
                                <DiseaseStage>Chronic</DiseaseStage>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Primary induction in vitro</ProcessType>
                                <ResponderCellType>PBMC</ResponderCellType>
                                <StimulatorCellType>PBMC</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>QKGRGSRGQHQAHSLERVCH</LinearSequence>
                                            <StartingPosition>121</StartingPosition>
                                            <EndingPosition>140</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P60201.2</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>9606</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>Patients with definitive MS clinically characterized predominantly as early RR MS were included in the study. Patients had at least two exacerbations within the previous 24 months and positive lesions on magnetic resonance imaging at the time of blood drawing, and had not received corticosteroids for at least 10 months before the study. The average expanded disability status scale (EDSS) score was 2.5 ± 1.7. T cell lines were established by stimulation with the epitope.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>T cell</CellType>
                            <CellCultureConditions>Cell Line / Clone</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>436</MhcAlleleId>
                            <MhcEvidenceCode>MHC binding assay</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>QKGRGSRGQHQAHSLERVCH</LinearSequence>
                                        <StartingPosition>121</StartingPosition>
                                        <EndingPosition>140</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P60201.2</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>9606</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>69</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Tables 4 and 5</LocationOfData>
                        <MhcBindingId>201416</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>1</AssayTypeId>
                            <QualitativeMeasurement>Positive-Low</QualitativeMeasurement>
                            <QuantitativeMeasurement>6000.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>436</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 5</LocationOfData>
                        <MhcBindingId>201418</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>417</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <QuantitativeMeasurement>250000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&gt;</MeasurementInequality>
                        </AssayInformation>
                        <MhcAlleleId>345</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Tables 4 and 5</LocationOfData>
                        <MhcBindingId>201420</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>417</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <QuantitativeMeasurement>250000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&gt;</MeasurementInequality>
                        </AssayInformation>
                        <MhcAlleleId>368</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 5</LocationOfData>
                        <MhcBindingId>201414</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>417</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <QuantitativeMeasurement>250000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&gt;</MeasurementInequality>
                        </AssayInformation>
                        <MhcAlleleId>340</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 5</LocationOfData>
                        <MhcBindingId>201419</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>1</AssayTypeId>
                            <QualitativeMeasurement>Positive-Low</QualitativeMeasurement>
                            <QuantitativeMeasurement>12000.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>347</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 5</LocationOfData>
                        <MhcBindingId>201415</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>1</AssayTypeId>
                            <QualitativeMeasurement>Positive-High</QualitativeMeasurement>
                            <QuantitativeMeasurement>490.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>341</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>p190-209</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>SKTSASIGSLCADARMYGVL</LinearSequence>
                        <StartingPosition>191</StartingPosition>
                        <EndingPosition>210</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P60201.2</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>9606</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 4</LocationOfData>
                <EpitopeId>58952</EpitopeId>
                <ReferenceStartingPosition>190</ReferenceStartingPosition>
                <ReferenceEndingPosition>209</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Representative selection</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>Imported from the TopBank database.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 4</LocationOfData>
                        <MhcBindingId>201423</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>1</AssayTypeId>
                            <QualitativeMeasurement>Positive-Low</QualitativeMeasurement>
                            <QuantitativeMeasurement>16000.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>368</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 4</LocationOfData>
                        <MhcBindingId>201422</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>1</AssayTypeId>
                            <QualitativeMeasurement>Positive-Intermediate</QualitativeMeasurement>
                            <QuantitativeMeasurement>1300.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>436</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>p40-59</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>TGTEKLIETYFSKNYQDYEY</LinearSequence>
                        <StartingPosition>41</StartingPosition>
                        <EndingPosition>60</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P60201.2</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>9606</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 4</LocationOfData>
                <EpitopeId>63975</EpitopeId>
                <ReferenceStartingPosition>40</ReferenceStartingPosition>
                <ReferenceEndingPosition>59</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Representative selection</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>Imported from the TopBank database.</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figures 1 and 2</LocationOfData>
                        <TCellId>1687436</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Occurrence of autoimmune disease</InVivoProcessType>
                                <DiseaseState>DOID:2377</DiseaseState>
                                <DiseaseStage>Chronic</DiseaseStage>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Primary induction in vitro</ProcessType>
                                <ResponderCellType>PBMC</ResponderCellType>
                                <StimulatorCellType>PBMC</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P60201.2</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>9606</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Representative selection</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>Patients with definitive MS clinically characterized predominantly as early RR MS were included in the study. Patients had at least two exacerbations within the previous 24 months and positive lesions on magnetic resonance imaging at the time of blood drawing, and had not received corticosteroids for at least 10 months before the study. The average expanded disability status scale (EDSS) score was 2.5 ± 1.7. T cell lines were established by stimulation with PLP.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>T cell</CellType>
                            <CellCultureConditions>Cell Line / Clone</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>368</MhcAlleleId>
                            <MhcEvidenceCode>MHC binding assay</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>TGTEKLIETYFSKNYQDYEY</LinearSequence>
                                        <StartingPosition>41</StartingPosition>
                                        <EndingPosition>60</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P60201.2</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>9606</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>69</AssayTypeId>
                            <QualitativeMeasurement>Positive-Low</QualitativeMeasurement>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figures 1 and 2</LocationOfData>
                        <TCellId>1687435</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Occurrence of autoimmune disease</InVivoProcessType>
                                <DiseaseState>DOID:2377</DiseaseState>
                                <DiseaseStage>Chronic</DiseaseStage>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Primary induction in vitro</ProcessType>
                                <ResponderCellType>PBMC</ResponderCellType>
                                <StimulatorCellType>PBMC</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P60201.2</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>9606</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Representative selection</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>Patients with definitive MS clinically characterized predominantly as early RR MS were included in the study. Patients had at least two exacerbations within the previous 24 months and positive lesions on magnetic resonance imaging at the time of blood drawing, and had not received corticosteroids for at least 10 months before the study. The average expanded disability status scale (EDSS) score was 2.5 ± 1.7. T cell lines were established by stimulation with PLP.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>T cell</CellType>
                            <CellCultureConditions>Cell Line / Clone</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>436</MhcAlleleId>
                            <MhcEvidenceCode>MHC binding assay</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>TGTEKLIETYFSKNYQDYEY</LinearSequence>
                                        <StartingPosition>41</StartingPosition>
                                        <EndingPosition>60</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P60201.2</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>9606</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>69</AssayTypeId>
                            <QualitativeMeasurement>Positive-Low</QualitativeMeasurement>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 4</LocationOfData>
                        <MhcBindingId>201424</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>1</AssayTypeId>
                            <QualitativeMeasurement>Positive-Low</QualitativeMeasurement>
                            <QuantitativeMeasurement>21000.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>436</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 4</LocationOfData>
                        <MhcBindingId>201425</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>1</AssayTypeId>
                            <QualitativeMeasurement>Positive-High</QualitativeMeasurement>
                            <QuantitativeMeasurement>190.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>368</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>p70-89</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>VIYGTASFFFLYGALLLAEG</LinearSequence>
                        <StartingPosition>71</StartingPosition>
                        <EndingPosition>90</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P60201.2</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>9606</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 4</LocationOfData>
                <EpitopeId>69164</EpitopeId>
                <ReferenceStartingPosition>70</ReferenceStartingPosition>
                <ReferenceEndingPosition>89</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Representative selection</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>Imported from the TopBank database.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 4</LocationOfData>
                        <MhcBindingId>201426</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>417</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <QuantitativeMeasurement>250000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&gt;</MeasurementInequality>
                        </AssayInformation>
                        <MhcAlleleId>436</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 4</LocationOfData>
                        <MhcBindingId>201427</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>1</AssayTypeId>
                            <QualitativeMeasurement>Positive-Intermediate</QualitativeMeasurement>
                            <QuantitativeMeasurement>4600.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>368</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>p160-179</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>VVWLLVFAACSAVPVYIYFNT</LinearSequence>
                        <SourceMolecule>
                            <IedbAccession>SRC279977</IedbAccession>
                        </SourceMolecule>
                        <SourceOrganismId>9606</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 4</LocationOfData>
                <EpitopeId>71892</EpitopeId>
                <ReferenceStartingPosition>160</ReferenceStartingPosition>
                <ReferenceEndingPosition>179</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Internal Identifier-no external match available</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>Imported from the TopBank database.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 4</LocationOfData>
                        <MhcBindingId>201429</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>1</AssayTypeId>
                            <QualitativeMeasurement>Positive-Intermediate</QualitativeMeasurement>
                            <QuantitativeMeasurement>3000.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>368</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 4</LocationOfData>
                        <MhcBindingId>201428</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>417</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <QuantitativeMeasurement>250000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&gt;</MeasurementInequality>
                        </AssayInformation>
                        <MhcAlleleId>436</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>p180-199</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>WTTCQSIAFPSKTSASIGSL</LinearSequence>
                        <StartingPosition>181</StartingPosition>
                        <EndingPosition>200</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P60201.2</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>9606</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 5</LocationOfData>
                <EpitopeId>73159</EpitopeId>
                <ReferenceStartingPosition>180</ReferenceStartingPosition>
                <ReferenceEndingPosition>199</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Representative selection</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>Imported from the TopBank database.</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figures 1, 2, 3, and 4, Tables II and III</LocationOfData>
                        <TCellId>1687440</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Occurrence of autoimmune disease</InVivoProcessType>
                                <DiseaseState>DOID:2377</DiseaseState>
                                <DiseaseStage>Chronic</DiseaseStage>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Primary induction in vitro</ProcessType>
                                <ResponderCellType>PBMC</ResponderCellType>
                                <StimulatorCellType>PBMC</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P60201.2</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>9606</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Representative selection</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>Patients with definitive MS clinically characterized predominantly as early RR MS were included in the study. Patients had at least two exacerbations within the previous 24 months and positive lesions on magnetic resonance imaging at the time of blood drawing, and had not received corticosteroids for at least 10 months before the study. The average expanded disability status scale (EDSS) score was 2.5 ± 1.7. T cell lines were established by stimulation with PLP.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>T cell</CellType>
                            <CellCultureConditions>Cell Line / Clone</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>436</MhcAlleleId>
                            <MhcEvidenceCode>MHC binding assay</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>WTTCQSIAFPSKTSASIGSL</LinearSequence>
                                        <StartingPosition>181</StartingPosition>
                                        <EndingPosition>200</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P60201.2</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>9606</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>69</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figures 1, 2, 3, and 4, Tables II and III</LocationOfData>
                        <TCellId>1687441</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Occurrence of autoimmune disease</InVivoProcessType>
                                <DiseaseState>DOID:2377</DiseaseState>
                                <DiseaseStage>Chronic</DiseaseStage>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Primary induction in vitro</ProcessType>
                                <ResponderCellType>PBMC</ResponderCellType>
                                <StimulatorCellType>PBMC</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P60201.2</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>9606</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Representative selection</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>Patients with definitive MS clinically characterized predominantly as early RR MS were included in the study. Patients had at least two exacerbations within the previous 24 months and positive lesions on magnetic resonance imaging at the time of blood drawing, and had not received corticosteroids for at least 10 months before the study. The average expanded disability status scale (EDSS) score was 2.5 ± 1.7. T cell lines were established by stimulation with PLP.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>T cell</CellType>
                            <CellCultureConditions>Cell Line / Clone</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>368</MhcAlleleId>
                            <MhcEvidenceCode>MHC binding assay</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>WTTCQSIAFPSKTSASIGSL</LinearSequence>
                                        <StartingPosition>181</StartingPosition>
                                        <EndingPosition>200</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P60201.2</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>9606</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>69</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 4 and Table VI</LocationOfData>
                        <TCellId>1687460</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Occurrence of autoimmune disease</InVivoProcessType>
                                <DiseaseState>DOID:2377</DiseaseState>
                                <DiseaseStage>Chronic</DiseaseStage>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Primary induction in vitro</ProcessType>
                                <ResponderCellType>PBMC</ResponderCellType>
                                <StimulatorCellType>PBMC</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>WTTCQSIAFPSKTSASIGSL</LinearSequence>
                                            <StartingPosition>181</StartingPosition>
                                            <EndingPosition>200</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P60201.2</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>9606</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>Patients with definitive MS clinically characterized predominantly as early RR MS were included in the study. Patients had at least two exacerbations within the previous 24 months and positive lesions on magnetic resonance imaging at the time of blood drawing, and had not received corticosteroids for at least 10 months before the study. The average expanded disability status scale (EDSS) score was 2.5 ± 1.7. T cell lines were established by stimulation with the epitope.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>T cell</CellType>
                            <CellCultureConditions>Cell Line / Clone</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>368</MhcAlleleId>
                            <MhcEvidenceCode>MHC binding assay</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>WTTCQSIAFPSKTSASIGSL</LinearSequence>
                                        <StartingPosition>181</StartingPosition>
                                        <EndingPosition>200</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P60201.2</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>9606</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>69</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 4 and Table VI</LocationOfData>
                        <TCellId>1687459</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Occurrence of autoimmune disease</InVivoProcessType>
                                <DiseaseState>DOID:2377</DiseaseState>
                                <DiseaseStage>Chronic</DiseaseStage>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Primary induction in vitro</ProcessType>
                                <ResponderCellType>PBMC</ResponderCellType>
                                <StimulatorCellType>PBMC</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>WTTCQSIAFPSKTSASIGSL</LinearSequence>
                                            <StartingPosition>181</StartingPosition>
                                            <EndingPosition>200</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P60201.2</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>9606</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>Patients with definitive MS clinically characterized predominantly as early RR MS were included in the study. Patients had at least two exacerbations within the previous 24 months and positive lesions on magnetic resonance imaging at the time of blood drawing, and had not received corticosteroids for at least 10 months before the study. The average expanded disability status scale (EDSS) score was 2.5 ± 1.7. T cell lines were established by stimulation with the epitope.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>T cell</CellType>
                            <CellCultureConditions>Cell Line / Clone</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>436</MhcAlleleId>
                            <MhcEvidenceCode>MHC binding assay</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>WTTCQSIAFPSKTSASIGSL</LinearSequence>
                                        <StartingPosition>181</StartingPosition>
                                        <EndingPosition>200</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P60201.2</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>9606</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>69</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 5</LocationOfData>
                        <MhcBindingId>201434</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>1</AssayTypeId>
                            <QualitativeMeasurement>Positive-Low</QualitativeMeasurement>
                            <QuantitativeMeasurement>174000.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>345</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 5</LocationOfData>
                        <MhcBindingId>201435</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>1</AssayTypeId>
                            <QualitativeMeasurement>Positive-High</QualitativeMeasurement>
                            <QuantitativeMeasurement>540.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>347</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 5</LocationOfData>
                        <MhcBindingId>201431</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>1</AssayTypeId>
                            <QualitativeMeasurement>Positive-High</QualitativeMeasurement>
                            <QuantitativeMeasurement>120.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>341</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 5</LocationOfData>
                        <MhcBindingId>201430</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>1</AssayTypeId>
                            <QualitativeMeasurement>Positive-Low</QualitativeMeasurement>
                            <QuantitativeMeasurement>87000.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>340</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Tables 4 and 5</LocationOfData>
                        <MhcBindingId>201436</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>1</AssayTypeId>
                            <QualitativeMeasurement>Positive-High</QualitativeMeasurement>
                            <QuantitativeMeasurement>270.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>368</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Tables 4 and 5</LocationOfData>
                        <MhcBindingId>201432</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>1</AssayTypeId>
                            <QualitativeMeasurement>Positive-High</QualitativeMeasurement>
                            <QuantitativeMeasurement>220.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>436</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
        </Epitopes>
    </Reference>
</References>

